Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for mucositis in head and neck cancer
NCT02480114Phase 3Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Jul 2015
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in mucositis comparing Standard of Care with Standard of Care + Gabapentin (2 arms). Primary endpoints: Change in Pain Associated With Radiation-induced Mucositis and Analgesic Use. Started Jul 2015; status: completed.
02
Drugs
gabapentin
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT02480114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02480114.